230 Publications (Page 6 of 10)
2013
An integrated pharmacokinetics ontology and corpus for text miningWu, Heng-Yi⋅Wu, Heng-Yi⋅Karnik, Shreyas⋅Karnik, Shreyas⋅Subhadarshini, Abhinita⋅Subhadarshini, Abhinita⋅Wang, Zhiping⋅Wang, Zhiping⋅Philips, Santosh⋅Philips, Santosh⋅Han, Xu⋅Han, Xu⋅Chiang, Chienwei⋅Chiang, Chienwei⋅Liu, Lei⋅Liu, Lei⋅Boustani, Malaz⋅Boustani, Malaz⋅Rocha, Luis M⋅Rocha, Luis M⋅Quinney, Sara K⋅Quinney, Sara K⋅Flockhart, David⋅Flockhart, David⋅Li, Lang and Li, LangBMC Bioinformatics, vol. 14, (no. 1), pp. 35, 2013.
| Journal Article
An integrated pharmacokinetics ontology and corpus for text mining.Wu, Heng-Yi⋅Karnik, Shreyas⋅Subhadarshini, Abhinita⋅Wang, Zhiping⋅Philips, Santosh⋅Han, Xu⋅Chiang, Chienwei⋅Liu, Lei⋅Boustani, Malaz⋅Rocha, Luis M⋅Quinney, Sara K⋅Flockhart, David and Li, LangBMC bioinformatics, vol. 14, pp. 35, 2013.
| Journal Article
COMPARISON OF POPULATION PHARMACOKINETIC AND PHYSIOLOGIC BASED PHARMACOKINETIC MODELS FOR VINCRISTINE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA.Quinney, S. K.⋅Chiang, C.⋅Li, C. H.⋅Li, L.⋅Bies, R. R.⋅Egbelakin, A.⋅Ho, R.⋅Hutchinson, R.⋅Smith, E. L.⋅Wells, E. and Renbarger, J. L.(pp. S119)
COMPARISON OF POPULATION PHARMACOKINETIC AND PHYSIOLOGIC BASED PHARMACOKINETIC MODELS FOR VINCRISTINE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA.Quinney, S. K.⋅Chiang, C.⋅Li, C. H.⋅Li, L.⋅Bies, R. R.⋅Egbelakin, A.⋅Ho, R.⋅Hutchinson, R.⋅Smith, E. L.⋅Wells, E. and Renbarger, J. L.Clinical Pharmacology & Therapeutics, vol. 93, pp. S119.
| Journal Article
COMPARISON OF POPULATION PHARMACOKINETIC AND PHYSIOLOGIC BASED PHARMACOKINETIC MODELS FOR VINCRISTINE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA. Clinical Pharmacology & Therapeutics
. | Journal Article
CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modeling.Xu, Cong⋅Quinney, Sara K⋅Guo, Yingying⋅Hall, Stephen D⋅Li, Lang and Desta, ZeruesenayDrug metabolism and disposition: the biological fate of chemicals, vol. 41, (no. 12), pp. 2004-11, 2013/Dec.
| Journal Article
CYP2B6 Pharmacogenetics-Based In Vitro-In Vivo Extrapolation of Efavirenz Clearance by Physiologically Based Pharmacokinetic Modeling. Drug Metabolism and Disposition
. | Journal Article
Integration of in vitro binding mechanism into the semiphysiologically based pharmacokinetic interaction model between ketoconazole and midazolam.Quinney, Sara K⋅Knopp, Shawn⋅Chang, Chien⋅Hall, Stephen D and Li, LangCPT: pharmacometrics & systems pharmacology, vol. 2, pp. e75, 2013.
| Journal Article
Integration of In Vitro Binding Mechanism Into the Semiphysiologically Based Pharmacokinetic Interaction Model Between Ketoconazole and Midazolam. CPT: Pharmacometrics & Systems Pharmacology
. | Journal Article
NEW MYOTOXIC DRUG INTERACTIONS BETWEEN STATINS AND RIFAMPICINHan, X.⋅Quinney, S.⋅Skaar, T.⋅Elmendord, J.⋅Flockhart, D. and Li, L.Clinical Pharmacology & Therapeutics, vol. 93, pp. S44.
| Journal Article
NEW MYOTOXIC DRUG INTERACTIONS BETWEEN STATINS AND RIFAMPICINHan, X.⋅Quinney, S.⋅Skaar, T.⋅Elmendord, J.⋅Flockhart, D. and Li, L.(pp. S44)
NEW MYOTOXIC DRUG INTERACTIONS BETWEEN STATINS AND RIFAMPICIN. Clinical Pharmacology & Therapeutics
. | Journal Article
Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.Haas, David M⋅Quinney, Sara K⋅Clay, Jayanti M⋅Renbarger, Jamie L⋅Hebert, Mary F⋅Clark, Shannon⋅Umans, Jason G and Caritis, Steve NAmerican journal of perinatology, vol. 30, (no. 4), pp. 275-81, 2013/Apr.
| Journal Article
Nifedipine Pharmacokinetics Are Influenced by CYP3A5 Genotype When Used as a Preterm Labor Tocolytic. American Journal of Perinatology
. | Journal Article
PHARMACOKINETICS OF R- AND S-PANTOPRAZOLE IN PREGNANT WOMENMohamed, A. N.⋅Glassburn, J.⋅Hebert, M. F.⋅Hankins, G. V.⋅Caritis, S. N.⋅Renbarger, J. L.⋅Quinney, S. K. and Res, Obstetric-Fetal Pharmacology(pp. S86)
PHARMACOKINETICS OF R- AND S-PANTOPRAZOLE IN PREGNANT WOMENMohamed, A. N.⋅Glassburn, J.⋅Hebert, M. F.⋅Hankins, G. V.⋅Caritis, S. N.⋅Renbarger, J. L.⋅Quinney, S. K. and Res, Obstetric-Fetal PharmacologyClinical Pharmacology & Therapeutics, vol. 93, pp. S86.
| Journal Article
PHARMACOKINETICS OF R- AND S-PANTOPRAZOLE IN PREGNANT WOMEN. Clinical Pharmacology & Therapeutics
. | Journal Article
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycinQuinney, Sara K⋅Malireddy, Srikar R⋅Vuppalanchi, Raj⋅Hamman, Mitchell A⋅Chalasani, Naga⋅Gorski, J. C and Hall, Stephen DEuropean Journal of Clinical Pharmacology, vol. 69, (no. 3), pp. 439-48, Mar 2013.
| Journal Article
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin. European Journal of Clinical Pharmacology
. | Journal Article
2012
A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic.Haas, David M⋅Quinney, Sara K⋅McCormick, Catherine L⋅Jones, David R and Renbarger, Jamie LThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, vol. 25, (no. 4), pp. 419-23, 2012/Apr.
| Journal Article
A semi-mechanistic metabolism model of CYP3A substrates in pregnancy: Predicting changes in midazolam and nifedipine pharmacokineticsQuinney, S K⋅Quinney, S.K.⋅Mohamed, A N⋅Mohamed, A.N.⋅Hebert, M F⋅Hebert, M.F.⋅Haas, D M⋅Haas, D.M.⋅Clark, S⋅Clark, S.⋅Umans, J.G.⋅Umans, J G⋅Caritis, S.N.⋅Caritis, S N⋅Li, L. and Li, LCPT: Pharmacometrics and Systems Pharmacology, vol. 1.
| Journal Article
A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics. CPT: Pharmacometrics & Systems Pharmacology
. | Journal Article
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.Miao, J⋅Jin, Y⋅Marunde, R L⋅Gorski, C J⋅Kim, S⋅Quinney, Sara K⋅Radovich, M⋅Li, L and Hall, S DThe pharmacogenomics journal, vol. 12, (no. 2), pp. 184, 2012/Apr.
| Journal Article
COMPARTMENTAL PHARMACOKINETICS (PK) OF IMMEDIATE RELEASE NIFEDIPINE (NIP) IN PREGNANCY: VARIABILITY IN ABSORPTIONNader, A. M.⋅Caritis, S. N.⋅Hebert, M. F.⋅Clark, S. M.⋅Flockhart, D. A.⋅Quinney, S. K. and Pharmacology, NICHD Obstet-Fetal(pp. S135)
COMPARTMENTAL PHARMACOKINETICS (PK) OF IMMEDIATE RELEASE NIFEDIPINE (NIP) IN PREGNANCY: VARIABILITY IN ABSORPTIONNader, A. M.⋅Caritis, S. N.⋅Hebert, M. F.⋅Clark, S. M.⋅Flockhart, D. A.⋅Quinney, S. K. and Pharmacology, NICHD Obstet-FetalClinical Pharmacology & Therapeutics, vol. 91, pp. S135.
| Journal Article